or Try an Advanced Search...

    Technical Analysis for VINC - Vincera Pharma, Inc.

    Grade Last Price % Change Price Change
    F 0.90 -3.58% -0.03
    VINC closed down 3.58 percent on Thursday, April 25, 2024, on 43 percent of normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions. Due to the stock's strong downtrend, it may remain oversold for a while. So, if you're looking for a reason to buy, don't put too much weight on it being oversold.
    Earnings due: May 9
    *** please verify all earnings dates ***
    2 Watchers
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Strong Down Down Down
    Historical VINC trend table...
    Date Alert Name Type % Chg
    NR7 Range Contraction 0.00%
    Narrow Range Bar Range Contraction 0.00%
    Wide Bands Range Expansion 0.00%
    Oversold Stochastic Weakness 0.00%
    Narrow Range Bar Range Contraction -3.58%
    Wide Bands Range Expansion -3.58%
    Oversold Stochastic Weakness -3.58%
    Narrow Range Bar Range Contraction -5.61%
    Wide Bands Range Expansion -5.61%
    Oversold Stochastic Weakness -5.61%
    Older End-of-Day Signals for VINC ...

       Recent Intraday Alerts

    Alert Time
    Possible NR7 about 14 hours ago
    Down 5% about 15 hours ago
    60 Minute Opening Range Breakdown about 17 hours ago
    Fell Below Previous Day's Low about 17 hours ago
    10 DMA Support about 17 hours ago
    View Earlier Intraday Alerts

    Get this analysis on your stocks daily!

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Analyze My Stocks!
    Configure default chart indicators
    VINC Chart by TradingView
    Basic chart:

    Profile

    Vincera Pharma, Inc., a clinical-stage biopharmaceutical company, researches and develops new therapies to address unmet medical needs for the treatment of cancer. The company's lead product candidate is VIP152 that is in clinical trials. Its drug candidates are in development for the treatment of solid tumors, leukemia, B-cell malignancies, lymphomas, and myelodysplastic syndrome. Vincera Pharma, Inc. is based in Santa Clara, California.
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Medicine Biopharmaceutical Cancer Clinical Medicine Solid Tumors Treatment Of Cancer Lymphoma Hematology Leukemia Myelodysplastic Syndrome Anatomical Pathology

    Is VINC a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 0 bullish, 4 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Apr 25 Vincerx Pharma announces proposed underwritten public offering of common stock and warrants
    Apr 25 Vincerx Pharma Announces Proposed Underwritten Public Offering of Common Stock and Warrants
    Apr 9 Vincerx (VINC) Tumbles on Results From Cancer Therapy Study
    Apr 9 Why Tilray Brands Shares Are Trading Lower By Around 22%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
    Apr 9 Why Is Small-Cap Cancer Focused Vincerx Pharma Stock Plummeting On Tuesday?
    Apr 9 Dow Dips 150 Points; Laser Photonics Shares Spike Higher
    Apr 9 Vincerx in selloff after early-stage data for cancer therapy
    Apr 9 Why Biophytis Shares Are Trading Higher By Around 55%; Here Are 20 Stocks Moving Premarket
    Apr 8 Vincerx Pharma Presents Positive Preliminary Phase 1 Data for VIP236 and Updates on Pipeline Progress at the American Association for Cancer Research (AACR) Annual Meeting 2024
    Apr 1 Vincerx to Host Virtual Investor Event Reviewing Preliminary Phase 1 VIP236 Data Presented at the American Association for Cancer Research (AACR) Annual Meeting 2024
    See more VINC news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 9.3722
    52 Week Low 0.61
    Average Volume 1,374,434
    200-Day Moving Average 1.73
    50-Day Moving Average 4.03
    20-Day Moving Average 2.62
    10-Day Moving Average 0.91
    Average True Range 0.56
    RSI (14) 31.03
    ADX 35.18
    +DI 17.38
    -DI 38.92
    Chandelier Exit (Long, 3 ATRs) 5.16
    Chandelier Exit (Short, 3 ATRs) 2.43
    Upper Bollinger Bands 7.25
    Lower Bollinger Band -2.02
    Percent B (%b) 0.31
    BandWidth 354.04
    MACD Line -1.10
    MACD Signal Line -0.99
    MACD Histogram -0.1079
    Fundamentals Value
    Market Cap 19.17 Million
    Num Shares 21.4 Million
    EPS -2.31
    Price-to-Earnings (P/E) Ratio -0.39
    Price-to-Sales 0.00
    Price-to-Book 1.83
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 0.97
    Resistance 3 (R3) 0.97 0.95 0.96
    Resistance 2 (R2) 0.95 0.93 0.95 0.96
    Resistance 1 (R1) 0.92 0.92 0.91 0.92 0.95
    Pivot Point 0.90 0.90 0.90 0.90 0.90
    Support 1 (S1) 0.87 0.88 0.86 0.87 0.84
    Support 2 (S2) 0.85 0.87 0.85 0.84
    Support 3 (S3) 0.82 0.85 0.83
    Support 4 (S4) 0.82